BCI on the Road

Print
PDF

Dr Jude Fitzgibbon speaking to lymphoma support group at Basildon University Hospital

on 18 July 2011.

Basildon_NHSLeukaemia_and_lymphoma_research

Dr Jude Fitzgibbon in the Centre for Haemato-Oncology is speaking to the lymphoma support group at Baslidon University Hospital on Monday 18 July, about his research funded by the Leukemia and Lymphoma Research Charity.

Follicular lymphoma (FL) is an incurable cancer of the B-cells, representing 25% of all Non-Hodgkin's Lymphomas.

It nearly always affects adults, and the average age at diagnosis is 60.

It is characterised by upregulation of a survival protein called BCL2 and the accumulation of a long lived pool of B cells, in which additional mutational changes can occur.

We now know that many of these changes target the cells epigenetic machinery, altering the transcriptional control of many hundred of genes and switching B cells from a Œnormal¹ to a Œcancerous¹ path.

With funding from the Leukaemia Lymphoma Research Charity we are trying to understand how this switch is likely to occur and if by reversing its effects we can identify novel methods of treating this lymphoma. -Dr Jude Fitzgibbon 

Related links:

Print
PDF

Most influential discoveries in cancer - Prof Ian Hart invited to speak at Milestones in Cancer seminar series, Cologne

on 13 July 2011.

Nature_milestones_cancer  Cologne_University

Professor Ian Hart will be speaking at the Cologne Cancer Club at the University of Cologne as part of their Milestones in Cancer series.

This seminar series hosts speakers that have been featured in Nature Milestones Cancer, which highlight the most influential discoveries in the field of cancer over the past century.

Professor Hart will be speaking on “The role of integrin αvβ6 in determining carcinoma cell invasion and metastasis.” Milestone 1 Seed and soil hypothesis.

You might also like:

Print
PDF

The 16th European Haematology Association Congress, see who’s presenting from the BCI

on 05 June 2011.

EHA_london_imageEHA_logo
The EHA congresses present the latest scientific and clinical research in all aspects of hematology, as well as ‘state of the art’ Education Sessions for clinicians and hematologists in training. This year the 16th EHA Congress will take place in London, UK on the 9-12th June 2011.

A group of BCI researchers from our Centre for Haemato-Oncology will be presenting their work at the congress, if you are attending please drop by and see them present their work.

Sessions:

View all our senior researchers working on Haematological Malignancies.